|
|
||||||||



*
Division of Clinical Immunology and Allergy and
Section of Pharmacology, Department of Neuroscience, University of Naples Federico II, Naples, Italy
Increasing evidence suggests that a continuous release of histamine
from mast cells occurs in the airways of asthmatic patients and that
histamine may modulate functions of other inflammatory cells such as
macrophages. In the present study histamine
(10-910-6 M) increased in a
concentration-dependent fashion the basal release of
-glucuronidase
(EC50 = 8.2 ± 3.5 x 10-9 M)
and IL-6 (EC50 = 9.3 ± 2.9 x
10-8 M) from human lung macrophages. Enhancement of
-glucuronidase release induced by histamine was evident after 30 min
and peaked at 90 min, whereas that of IL-6 required 26 h of
incubation. These effects were reproduced by the H1 agonist
(6-[2-(4-imidazolyl)ethylamino]-N-(4-trifluoromethylphenyl)heptane
carboxamide but not by the H2 agonist dimaprit.
Furthermore, histamine induced a concentration-dependent increase of
intracellular Ca2+ concentrations
([Ca2+]i) that followed three types of
response, one characterized by a rapid increase, a second in which
[Ca2+]i displays a slow but progressive
increase, and a third characterized by an oscillatory pattern.
Histamine-induced
-glucuronidase and IL-6 release and
[Ca2+]i elevation were inhibited by the
selective H1 antagonist fexofenadine
(10-710-4 M), but not by the H2
antagonist ranitidine. Inhibition of histamine-induced
-glucuronidase and IL-6 release by fexofenadine was concentration
dependent and displayed the characteristics of a competitive antagonism
(Kd = 89 nM). These data demonstrate
that histamine induces exocytosis and IL-6 production from human
macrophages by activating H1 receptor and by increasing
[Ca2+]i and they suggest that histamine may
play a relevant role in the long-term sustainment of allergic
inflammation in the airways.
This article has been cited by other articles:
![]() |
M.J. Wigglesworth, K.J. Lawless, D.J. Standing, E.K. Mackenzie, V.R. Kitchen, F. Mckay, E. Ward, S.J. Brough, M. Stylianou, F.R. Jewitt, et al. Use of Cryopreserved Cells for Enabling Greater Flexibility in Compound Profiling J Biomol Screen, June 1, 2008; 13(5): 354 - 362. [Abstract] [PDF] |
||||
![]() |
R. Noubade, N. Saligrama, K. Spach, R. del Rio, E. P. Blankenhorn, T. Kantidakis, G. Milligan, M. Rincon, and C. Teuscher Autoimmune Disease-Associated Histamine Receptor H1 Alleles Exhibit Differential Protein Trafficking and Cell Surface Expression J. Immunol., June 1, 2008; 180(11): 7471 - 7479. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. W Khan and U. Rai Differential effects of histamine on Leydig cell and testicular macrophage activities in wall lizards: precise role of H1/H2 receptor subtypes J. Endocrinol., August 1, 2007; 194(2): 441 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wimmer, S. K. Khaldoyanidi, M. Judex, N. Serobyan, R. G. DiScipio, and I. U. Schraufstatter CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes Blood, December 1, 2006; 108(12): 3722 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. H. Mauban, K. Wilkinson, C. Schach, and J. X.-J. Yuan Histamine-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells Am J Physiol Cell Physiol, February 1, 2006; 290(2): C325 - C336. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K.C. Lee, G. P. Currie, B. J. Lipworth, E. L. Altschuler, R. E. Kast, and F. E. R. Simons H1-Antihistamines N. Engl. J. Med., March 17, 2005; 352(11): 1155 - 1157. [Full Text] [PDF] |
||||
![]() |
F. E. R. Simons Advances in H1-Antihistamines N. Engl. J. Med., November 18, 2004; 351(21): 2203 - 2217. [Full Text] [PDF] |
||||
![]() |
V. Temkin, B. Kantor, V. Weg, M.-L. Hartman, and F. Levi-Schaffer Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release J. Immunol., September 1, 2002; 169(5): 2662 - 2669. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |